SAVICELL CORP
Profile
Company Names
SAVICELL CORP
ONLINE DISRUPTIVE TECHNOLOGIES, INC.
Addresses
10 STEVENS STREET, PO BOX 1080, ANDOVER, MA 01810-3572
10 STEVENS STREET, BOX 1080, ANDOVER, MA 01810-3572
10 STEVENS STREET, ANDOVER, MA 01810-3572
3120 S. DURANGO DRIVE, SUITE 305, LAS VEGAS, NV 89117
Phone Numbers
978-474-4016
978-886-1071
702-579-7900
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, OTHER
Year Incorporated:
2009
State Incorporated:
NEVADA
Total Amount Raised:
$1,490,582.00
Number of Funding Rounds:
13
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
13
2023-08-11
$224,000.00
$224,000.00
$0.00
Equity
12
2022-11-04
$174,999.00
$174,999.00
$0.00
Equity
11
2021-10-13
$113,000.00
$113,000.00
$0.00
Equity
10
2020-12-24
$17,850.00
$17,850.00
$0.00
Equity
9
2020-12-03
$300,000.00
$300,000.00
$0.00
Equity
8
2019-10-25
$12,000.00
$12,000.00
$0.00
Equity
7
2019-04-12
$50,000.00
$50,000.00
$0.00
Equity
6
2019-03-04
$50,000.00
$50,000.00
$0.00
Equity
5
2017-12-28
$200,000.00
$200,000.00
$0.00
Equity
4
2017-05-04
$250,000.00
$250,000.00
$0.00
Equity
3
2012-12-04
$21,000.00
$21,000.00
$0.00
Equity
2
2012-11-16
$68,733.00
$68,733.00
$0.00
Equity
1
2012-07-30
$9,000.00
$9,000.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
IRIT
ARBEL
DIRECTOR, EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2023-08-11
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2022-11-04
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2021-10-13
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2020-12-24
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2020-12-03
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2019-10-25
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2019-04-12
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2019-03-04
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2017-12-28
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2017-05-04
D
OTHER
SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
DECLINE TO DISCLOSE
Equity
2012-12-04
D
OTHER
SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
DECLINE TO DISCLOSE
Equity
2012-11-16
D/A
OTHER
SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
DECLINE TO DISCLOSE
Equity
2012-07-30
D
OTHER
SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
DECLINE TO DISCLOSE
Equity
2012-07-30
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
